Skip to main content
. 2019 May 1;155(6):673–678. doi: 10.1001/jamadermatol.2019.0425

Figure 2. Overall Survival and Progression-Free Survival According to Treatment and Time to Recurrence.

Figure 2.

A, Overall survival according to treatment. B, Progression-free survival according to treatment. C, Overall survival according to the time to recurrence (<12 months, 12-24 months, or >24 months). D, Progression-free survival according to the time to recurrence (<12 months, 12-24 months, or >24 months). HR indicates hazard ratio.